This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 4;379(9814):390-2.

doi: 10.1016/S0140-6736(11)61823-0. Epub 2011 Dec 5.

The 2011 EBCTCG polychemotherapy overview

Carlo Palmieri¹, Alison Jones

Affiliations

PMID: 22152852
DOI: 10.1016/S0140-6736(11)61823-0

Comment

The 2011 EBCTCG polychemotherapy overview

Carlo Palmieri et al. Lancet. 2012.

. 2012 Feb 4;379(9814):390-2.

doi: 10.1016/S0140-6736(11)61823-0. Epub 2011 Dec 5.

Authors

Carlo Palmieri¹, Alison Jones

Affiliation

¹ Division of Cancer, Imperial College London, London W12 0NN, UK. c.palmieri@imperial.ac.uk

PMID: 22152852
DOI: 10.1016/S0140-6736(11)61823-0

No abstract available

PubMed Disclaimer

Comment on

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Lancet. 2012 Feb 4;379(9814):432-44. doi: 10.1016/S0140-6736(11)61625-5. Epub 2011 Dec 5. Lancet. 2012. PMID: 22152853 Free PMC article.

Similar articles

An interpretation of the EBCTCG data.
Lewis JP. Lewis JP. Oncologist. 2007 May;12(5):505-9. doi: 10.1634/theoncologist.12-5-505. Oncologist. 2007. PMID: 17522235 Review.
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 19;352(9132):930-42. Lancet. 1998. PMID: 9752815
Polychemotherapy for early breast cancer.
Rodger A. Rodger A. Lancet. 2001 Dec 22-29;358(9299):2170. doi: 10.1016/S0140-6736(01)07203-8. Lancet. 2001. PMID: 11784664 No abstract available.
Polychemotherapy for early breast cancer.
Baum M. Baum M. Lancet. 1998 Nov 7;352(9139):1554. doi: 10.1016/S0140-6736(05)60364-9. Lancet. 1998. PMID: 9820329 No abstract available.
Adjuvant chemotherapy in early breast cancer.
Ejlertsen B. Ejlertsen B. Dan Med J. 2016 May;63(5):B5222. Dan Med J. 2016. PMID: 27127018 Review.

See all similar articles

Cited by

Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study.
de Oliveira C, Bremner KE, Pataky R, Gunraj N, Haq M, Chan K, Cheung WY, Hoch JS, Peacock S, Krahn MD. de Oliveira C, et al. CMAJ Open. 2013 Dec 9;1(4):E151-8. doi: 10.9778/cmajo.20130041. eCollection 2013 Oct. CMAJ Open. 2013. PMID: 25077117 Free PMC article.
In reply.
Xu B, Seidman A, Chan S. Xu B, et al. Oncologist. 2015 Jan;20(1):88. doi: 10.1634/theoncologist.2014-0284. Oncologist. 2015. PMID: 25589501 Free PMC article.
Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients.
Taubenhansl C, Ortmann O, Gerken M, Inwald EC, Klinkhammer-Schalke M. Taubenhansl C, et al. Arch Gynecol Obstet. 2020 Feb;301(2):573-583. doi: 10.1007/s00404-019-05387-3. Epub 2019 Nov 20. Arch Gynecol Obstet. 2020. PMID: 31749031 Free PMC article.
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.
Miller E, Lee HJ, Lulla A, Hernandez L, Gokare P, Lim B. Miller E, et al. F1000Res. 2014 Aug 19;3:198. doi: 10.12688/f1000research.4340.1. eCollection 2014. F1000Res. 2014. PMID: 25400908 Free PMC article. Review.
The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?
Johnston SR, Yeo B. Johnston SR, et al. Curr Oncol Rep. 2014;16(1):358. doi: 10.1007/s11912-013-0358-9. Curr Oncol Rep. 2014. PMID: 24390724 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information